AstraZeneca underpaid hundreds of female and Hispanic sales reps, feds saynews2021-10-04T20:17:00+00:00October 4th, 2021|Fierce Pharma|
Researchers retract preprint study that miscalculated higher heart inflammation risk for Moderna, Pfizer COVID vaccinesnews2021-10-04T14:54:23+00:00October 4th, 2021|Fierce Pharma|
Teva puts the brakes on troubled California sterile injectables plant: reportsnews2021-10-04T14:51:46+00:00October 4th, 2021|Fierce Pharma|
Arcutis, with Amgen in its crosshairs, seeks FDA approval for topical psoriasis drugnews2021-10-04T14:10:12+00:00October 4th, 2021|Fierce Pharma|
Celltrion makes case for Remicade biobetter with subcut switch datanews2021-10-04T14:05:01+00:00October 4th, 2021|Fierce Pharma|
After settling criminal price-fixing case, Novartis’ Sandoz inks $185M civil deal with fedsnews2021-10-04T13:39:19+00:00October 4th, 2021|Fierce Pharma|
Bayer recalls antifungal aerosol sprays on carcinogen contamination concernsnews2021-10-04T13:25:56+00:00October 4th, 2021|Fierce Pharma|
Gilead’s Kite enters leukemia with Tecartus FDA approval, overlapping Novartis’ CAR-T rival Kymriahnews2021-10-04T13:23:28+00:00October 4th, 2021|Fierce Pharma|
Racing rival Pfizer, Merck’s Vaxneuvance makes its case for an FDA approval in childrennews2021-10-03T15:43:30+00:00October 3rd, 2021|Fierce Pharma|
Judge denies Pfizer’s request to run 2 programs to subsidize patients for expensive heart drugnews2021-10-01T19:46:34+00:00October 1st, 2021|Fierce Pharma|
